Mangrove Partners Anebulo Pharmaceuticals, Inc. Call Options Transaction History
Mangrove Partners
- $691 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANEB
# of Institutions
19Shares Held
22.2MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA15.5MShares$39.4 Million18.72% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.04MShares$7.74 Million0.19% of portfolio
-
Morgan Stanley New York, NY399KShares$1.02 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA216KShares$550,6750.0% of portfolio
-
Geode Capital Management, LLC Boston, MA206KShares$524,5860.0% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $65.4M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...